MEMORANDUM Vaccine Institute . can be foreseen for this organization, due to the
TO: Dr. R.J. Wilson
FROM: R.E. Binnerts .
SUBJECT: Competition in Biologicals for Human Use
With reference to your request, I am setting out below my observations on the future of major manufacturers of biologicals for human use (excluding State-owned organizations).
Please note that these comments pertain solely to human preparations, not to to biologicals for veterinary or poultry use.
Please bear in mind that these are based on the assumption that international trade is mandatory for a biological organization to survive.
1. Behringwerke
An extremely viable operation, and one which can give Connaught a considerable amount of competition mainly in Latin America, due to their policy of establishing their own basic manufacturing facilities in various countries such as Brazil and Argentina. They have their own limited production of biologicals for human use in Mexico.
However, also an organization which is anxious to reach a co-operation with Connaught in every field possible, as demonstrated by the current negotiations on processing of ERA Rabies Vaccine in Mexico and Latin America.
2. R.I.T.
An organization which appears to be getting out of the production of items for routine immunization, such as diphtheria, tetanus, whooping cough, etc. in favour of concentrating on developing a few specialized and high revenue-producing items.
3. Merieux
The future activities of this organization in the biological field, excluding blood derivatives, are hard to predict, once Dr. Merieux leaves. My personal experience with Rhone-Poulenc/May & Baker leads me to believe that, with the exception of bidding on tenders from some ex-British and ex-French colonies, little active sales promotion for biologicals will be carried out by this group in future.